Immunoglobulin response to adjuvanted-PHA/PMB2 (polyhydroxyalkanoate/P. multocida serotype B:2) vaccine

Published: 2 March 2021| Version 2 | DOI: 10.17632/dynk8rxbdd.2


Data on the response of immunoglubulins IgG, IgM, and IgA towards adjuvanted-PHA/PMB2 vaccine (adjuvanted-polyhydroxyalkanoate/P. multocida serotype B:2 vaccine) showed extended release and effectivity of vaccine with the use of polyhydroxyalkanoate (PHA) as an adjuvant in Sprague Dawley (SD) rats throughout an eight-week experiment. Data consists of raw and statistical analysis results on the changes in immunoglobulin concentrations (OD 450 nm) when four different treatment groups were administered intramuscular (IM) injection: 1) non-treatment as control, 2) P(3HB) adjuvant, 3) PMB2 vaccine, and 4) adjuvanted-P(3HB)/PMB2 vaccine.


Steps to reproduce

Methodology will be described in detail in article.


Universiti Malaysia Terengganu


Biomaterials, Vaccine, Biopolymer, Biopolymer Immobilization, Nanoscale Biomaterials, Veterinary Bacteriology, Animal Vaccine